Krais, John J. http://orcid.org/0000-0002-3916-3435
Glass, David J.
Chudoba, Ilse
Wang, Yifan
Feng, Wanjuan
Simpson, Dennis
Patel, Pooja
Liu, Zemin
Neumann-Domer, Ryan
Betsch, Robert G.
Bernhardy, Andrea J.
Bradbury, Alice M.
Conger, Jason
Yueh, Wei-Ting
Nacson, Joseph
Pomerantz, Richard T. http://orcid.org/0000-0003-1194-9871
Gupta, Gaorav P. http://orcid.org/0000-0001-9177-552X
Testa, Joseph R. http://orcid.org/0000-0003-1301-5175
Johnson, Neil http://orcid.org/0000-0002-0276-0009
Article History
Received: 3 August 2023
Accepted: 9 November 2023
First Online: 24 November 2023
Competing interests
: G.P.G. has received research funding from Breakpoint Therapeutics and Merck. R.T.P. is a cofounder and chief scientific officer of Recombination Therapeutics, LLC. The remaining authors declare no competing interests.